The healthcare industry is "not even close" to standardizing healthcare business transactions and realizing the promise of a return on its investment in IT, even though the government deadline to do so passed nine months ago, according to results of a
The healthcare industry is "not even close" to standardizing healthcare business transactions and realizing the promise of a return on its investment in IT, even though the government deadline to do so passed nine months ago, according to results of a survey conducted by Phoenix Health Systems and the Healthcare Information and Management Systems Society. The deadline for meeting Health Insurance Portability and Accountability Act (HIPAA) Transactions and Codes Sets passed last October, yet the industry has made little progress toward standardizing healthcare business transactions.
Phoenix Health Systems found that many providers and payers may be ready to produce compliant transactions, but their trading partners cannot accept or transmit them. Survey results are based on responses from 540 healthcare industry representatives polled June 1 to 15. A return on investment and HIPAA compliance will be realized only when the industry as a whole decides to work together to conform to the guidelines, according to HIMSS.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.